Senior Scientist I
Novartis
Summary
Senior Scientist will work within a sub-team of OPB, primarily focused on tissue-based biomarker assay development (e.g., IHC, ISH, and FIHC) for eventual transfer to external contract research organizations as part of clinical trials or for exploratory research on preclinical and consented clinical and commercial samples.
Job description
About the Role
Senior Scientist will work within a sub-team of OPB, primarily focused on tissue-based biomarker assay development (e.g., IHC, ISH, and FIHC) for eventual transfer to external contract research organizations as part of clinical trials or for exploratory research on preclinical and consented clinical and commercial samples.
The Senior Scientist will help support programs across a wide range of therapeutic modalities and disease indications within Oncology and have opportunities to develop additional skills in image analysis and participate in technical development within OPB.
Key Responsibilities
- Lead tissue-based biomarker assay development including IHC, ISH, and FIHC
- Transfer assays to external contract research organizations for clinical trials
- Support exploratory research on preclinical and consented clinical and commercial samples
- Support programs across therapeutic modalities and disease indications within Oncology
- Develop additional skills in image analysis
- Participate in technical development within OPB
Requirements
- Master’s degree in biology, cell biology, neuroscience, or a related field
- 2 years of work experience in the job offered or related position
- Experience with immunohistochemical techniques
- Experience with immunofluorescence techniques
- Experience with histology
Benefits
- Health insurance
- Life insurance
- Disability benefits
- 401(k) with company match
- Vacation
- Personal days
- Holidays
- Performance-based cash incentive
- Annual equity awards
Company overview
Novartis is a global pharmaceutical company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. As an innovative medicines company, Novartis focuses on developing high-value treatments that address society's greatest disease burdens through technology leadership in research and development. The company operates across five core therapeutic areas: cardiovascular, renal and metabolic diseases; immunology; neuroscience; oncology; and hematology. With a workforce of approximately 75,883 employees worldwide, Novartis reaches nearly 300 million patients across 118 countries. The company leverages advanced technology platforms including targeted protein degradation, cell therapy, gene therapy, radioligand therapy, and xRNA to develop breakthrough treatments. Novartis maintains a strong portfolio of oncology drugs and generics while continuously expanding its pipeline through strategic acquisitions and internal research. The company's commitment extends beyond drug development to ensuring global access to medical innovations through novel access approaches and patient assistance programs.